Faculty Bios

FACULTY BIOGRAPHIES

Alan Menter, MD 
Baylor University Medical Center
U
niversity of Texas, Southwestern Medical Center
Baylor Psoriasis Research Center 


Dr. Alan Menter is chair of research for Dermatology at Baylor Research Institute, as well as clinical professor of dermatology at the University of Texas Southwestern Medical School in Dallas. Dr. Alan Menter is a graduate of the Medical School of the University of Witwatersrand, South Africa. He completed his dermatology residency at Pretoria General Hospital at the University of Pretoria, also in South Africa, and two fellowships in London at Guy’s Hospital and St. John’s Hospital for Diseases of the Skin. A fellowship with the University of Texas Southwestern Medical Center in Dallas brought Menter to the United States. Since then, he has held several positions within the University of Texas and Baylor University systems. In 1992, he was appointed chairman of the Division of Dermatology at Baylor University Medical Center and still holds that position. In 2007, he was appointed director of the Baylor Research Center and in 2010, Program Director of the newly formed Dermatology Residency Program at Baylor University Medical Center. 

Dr. Menter has a long-held interest in psoriasis and psoriatic disease research. In 1994, he co-authored the first gene discovery for psoriasis, published in Science that same year. His research on psoriasis has examined everything from ultraviolet phototherapy and biologic therapy to the mapping of genetic patterns to predict if a person is at risk of developing psoriasis. In August 2004, Dr. Menter helped found the International Psoriasis Council to raise international awareness of psoriasis as a serious autoimmune disease that can significantly impact quality of life. His clinical practice includes more than 1,600 patients on systemic and biologic therapy and phototherapy. His resume lists some 300+ articles, four books, and 19 book chapters. He serves as a member of the editorial board for several medical journals, including the Journal of Clinical Dermatology and Clinical and Experimental Dermatology. Dr. Menter has been listed in the Best Doctors in America since 1994 and Who’s Who in Medicine and Healthcare since 1996. 

DISCLOSURE OF CONFLICTS OF INTEREST
 
Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 


 
Andrew Blauvelt, MD, MBA 
Oregon Medical Research Center 


Andrew Blauvelt is President of the Oregon Medical Research Center, a small business dedicated to performing high quality clinical research studies in dermatology. Dr. Blauvelt received his undergraduate degree from Purdue University, his Doctor of Medicine degree at Michigan State University, and his healthcare Masters of Business Administration at the Oregon Health & Science University (OHSU). He then trained in dermatology at the University of Miami and in basic immunology research at the National Institutes of Health (NIH). Dr. Blauvelt has held staff positions at the NIH and more recently as Professor of Dermatology at OHSU and Chief of Dermatology at the Portland VA Medical Center. Dr. Blauvelt’s clinical and laboratory research expertise is in psoriasis, immunology, and infectious diseases. He has published over 140 papers and spoken across the country and world on these topics. Dr. Blauvelt has also served as principal investigator on numerous psoriasis clinical trials, is a key scientific advisor for numerous pharmaceutical companies involved in developing new psoriasis therapies, was a longstanding member of the Medical Advisory Board of the National Psoriasis Foundation, and is an elected member of the International Psoriasis Council. 

DISCLOSURE OF CONFLICTS OF INTEREST

Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

Andrew Blauvelt, MD, MBA, reported a financial interest/relationship or affiliation in the form of: Consulting Fee, Celgene Corporation, Janssen Pharmaceuticals, Inc., Lilly USA, Novartis Pharmaceuticals Corporation, Pfizer, Inc.; Speakers’ Bureau, Janssen Pharmaceuticals, Inc.; Contracted Research, Amgen, Inc., Janssen Pharmaceuticals, Inc., Lilly USA, Novartis Pharmaceuticals Corporation, Pfizer, Inc. 

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 


Jeffrey J. Crowley, MD 
Bakersfield Dermatology 


Dr. Jeffrey J. Crowley completed undergraduate, medical school, internship and residency in dermatology at Stanford University. After residency, he practiced at the Palo Alto Clinic before moving to Bakersfield in 1997 to join a private practice. At Bakersfield Dermatology and Skin Cancer Medical Group, Dr. Crowley has established a comprehensive center for the treatment of psoriasis. This center uses all modalities, including phototherapy and biologics, to manage patients with psoriasis. Dr. Crowley also heads a very busy clinical trial unit with active trials in psoriasis, atopic dermatitis, and hidradenitis suppurativa. He has served as principal investigator for over 30 clinical trials. He has published over a dozen peer-reviewed articles. Additionally, Dr. Crowley is a fellow of the American Academy of Dermatology and the American Society of Dermatologic Surgery, and member of CalDerm. He has served as clinical faculty for both Stanford University School of Medicine and the Geffen School of Medicine at the University of California, Los Angeles. 


DISCLOSURE OF CONFLICTS OF INTEREST

Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

Jeffrey J. Crowley, MD, reported a financial interest/relationship or affiliation in the form of: Consulting Fee, AbbVie, Amgen, Inc., Medac, Inc.; Speakers’ Bureau, AbbVie, Amgen, Inc.; Contracted Research , AbbVie;, Amgen, Inc., Celgene Corporation, Janssen Pharmaceuticals, Inc., Pfizer, Inc., Merck & Co., Inc., Lilly USA. 

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 
 


Neil J. Korman, MD, PhD 
University Hospitals Case Medical Center 


Neil J. Korman, MD, PhD, is a Professor of Dermatology at Case Western Reserve University in Cleveland, Ohio. He is also the director of the Dermatology Clinical Trials Unit in the Department of Dermatology at University Hospitals Case Medical Center. In addition, he serves as the clinical director of the Murdough Family Center for Psoriasis, a comprehensive psoriasis research, education, and treatment program. Dr. Korman earned his Doctor of Medicine degree and doctorate in biomedical engineering at Case Western Reserve University. His postdoctoral training included a medical internship and dermatology residency at University Hospitals of Cleveland and an immunodermatology fellowship at the National Institutes of Health in Bethesda, Maryland. 

Dr. Korman holds subspecialty board certification in dermatological immunology/diagnostic and laboratory immunology. He is a member of the American Dermatologic Association, the Psoriasis Expert Resource Group of the American Academy of Dermatology, and the Medical Advisory Board of the National Psoriasis Foundation and the International Pemphigus and Pemphigoid Foundation. He is the Founding Director of the Regional Center for Immunobullous Diseases. Dr. Korman has published over 160 articles in the peer-reviewed literature. He has served as an associate editor of Medical and Surgical Dermatology and serves on the editorial board of the Journal of Cutaneous Medicine and Surgery. He is a reviewer for numerous peer-reviewed journals. Since 1997, he has been the principal or co-principal investigator in more than 90 clinical trials, the majority of which have involved psoriasis. He is a regular speaker at national and international dermatology meetings. 

DISCLOSURE OF CONFLICTS OF INTEREST
 
Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

Neil Korman, MD, PhD, reported a financial interest/relationship or affiliation in the form of: Consulting Fee, ApoPharma Inc., Baxter, Celgene Corporation, Lilly USA, Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 
 


Craig L. Leonardi, M.D. 
St. Louis University Medical School 


 

Dr. Craig L. Leonardi is Clinical Professor of Dermatology at St. Louis University Medical School in St. Louis, Missouri, where he also has a private practice. He received his Doctor of Medicine degree from the University Of Miami School Of Medicine in Florida and completed an internship in pediatrics and residency in dermatology at the University of Miami/ Jackson Memorial Hospital. Dr. Leonardi is a fellow of the American Academy of Dermatology and member of the American Dermatological Association. He is a founding member and secretary-treasurer of the International Psoriasis Council. He has served as a member of the medical advisory board of the National Psoriasis Foundation. 


Dr. Leonardi has extensive experience using the new biologics in the treatment of psoriasis. He has been an invited speaker at national, regional, and state venues and serves on the advisory boards of several pharmaceutical companies. He has been involved in more than 190 clinical trials and has published more than 200 original articles and abstracts in such journals as the Journal of the American Academy of Dermatology, the British Journal of Dermatology, the Archives of Dermatology, the Journal of the American Medical Association, the New England Journal of Medicine and the Lancet. 

DISCLOSURE OF CONFLICTS OF INTEREST

Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

Craig L. Leonardi, MD, reported a financial interest/relationship or affiliation in the form of: Consulting Fee, AbbVie, Amgen, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Leo Pharma, Pfizer, Inc., Sandoz; Contracted Research, AbbVie, Amgen, Inc., Anacor Pharmaceuticals, Inc., Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Maruho Co., Ltd., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Pfizer, Inc., Leo Pharma, Stiefel Laboratories, Inc., Tolmar Inc., Warner Chilcott, Wyeth Pharmaceuticals; Speakers’ Bureau, AbbVie

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 
 


Caitriona Ryan, MD, MRCPI 
Baylor University Medical Center 




Caitriona Ryan received her medical degree from University College Dublin, Ireland in 2004. She completed an internal medicine residency and commenced her dermatology training at St. Vincent’s University Hospital in Dublin. Under the mentorship of Dr. Alan Menter, she completed a translational research fellowship at Baylor Institute of Immunology Research in Dallas. She is now a PGY4 dermatology resident at Baylor University Medical Center, and will join Dr. Menter as faculty at the residency next July on completion of her US residency. The majority of her dermatology research to date has focused on the immunobiology of psoriasis and pharmogenomics of psoriasis treatment. 

DISCLOSURE OF CONFLICTS OF INTEREST

Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

Caitriona Ryan, MD, MRCPI, reported a financial interest/relationship or affiliation in the form of: Consulting Fee, Pfizer, Inc. 
The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, Jocelyn Timko, BS and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 



April W. Armstrong, MD, MPH 
Vice Chair of Clinical Research
Associate Professor of Dermatology
Director, Clinical Trials and Outcomes Research
Director, Psoriasis Program
University of Colorado School of Medicine

 
Dr April W. Armstrong is Vice Chair of Clinical Research, Director of Clinical Trials and Outcomes Research, and Director of the Psoriasis Program in the Department of Dermatology at the University of Colorado School of Medicine in Denver. Dr Armstrong has expertise in outcomes research, psoriasis, and technology-enabled delivery of healthcare. She is recognized internationally for her efforts in telehealth technology to provide dermatology consultations to remote communities and underserved populations. 

The author of over 130 peer-reviewed scientific publications, Dr Armstrong also served as editor of the top pharmacology textbook, Principles of Pharmacology. She holds multiple leadership positions at professional societies, including serving as Vice Chair for Teledermatology SIG at the American Telemedicine Association, Medical Board Member of the National Psoriasis Foundation, Steering Committee Member for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and Task Force and Committee Member for multiple committees at the American Academy of Dermatology. Dr Armstrong also serves on the editorial boards of JAMA Dermatology, the Journal of the American Academy of Dermatology, and Telemedicine and eHealth. She was also past President of the Sacramento Valley Dermatologic Society. 

Dr Armstrong received her Doctor of Medicine degree from Harvard Medical School in Cambridge, Massachusetts, and completed her dermatology residency at Harvard Dermatology Residency Program. She also obtained a Master of Public Health degree from Harvard School of Public Health. 

DISCLOSURE OF CONFLICTS OF INTEREST

Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant: 

Alan Menter, MD, reported a financial interest/relationship or affiliation in the form of: Advisory Board, AbbVie, Amgen, Inc., Celgene Corporation, Galderma S.A., Janssen Pharmaceuticals, Inc.; Contracted Research, Celgene Corporation, Eli Lilly and Company, Galderma S.A., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Speakers’ Bureau, AbbVie, Amgen, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc. 

April W. Armstrong, MD, MPH, reported a financial interest/relationship or affiliation in the form of consulting fee, AbbVie, Amgen, Inc., Eli Lilly and Company, Merck & Co., Inc., Pfizer, Inc.; contracted research, Amgen, Inc., Eli Lilly and Company, Pfizer, Inc.

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Linda Gracie-King, MS, and Diedrea White, BA, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.